602 related articles for article (PubMed ID: 31734836)
1. Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance.
Najafi M; Farhood B; Mortezaee K; Kharazinejad E; Majidpoor J; Ahadi R
J Cancer Res Clin Oncol; 2020 Jan; 146(1):19-31. PubMed ID: 31734836
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cell (CSC) resistance drivers.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
Eun K; Ham SW; Kim H
BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance.
Najafi M; Mortezaee K; Ahadi R
Life Sci; 2019 Aug; 231():116520. PubMed ID: 31158379
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia as a biomarker for radioresistant cancer stem cells.
Peitzsch C; Perrin R; Hill RP; Dubrovska A; Kurth I
Int J Radiat Biol; 2014 Aug; 90(8):636-52. PubMed ID: 24844374
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.
Hajizadeh F; Okoye I; Esmaily M; Ghasemi Chaleshtari M; Masjedi A; Azizi G; Irandoust M; Ghalamfarsa G; Jadidi-Niaragh F
Life Sci; 2019 Nov; 237():116952. PubMed ID: 31622608
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia inducible factors in cancer stem cells.
Heddleston JM; Li Z; Lathia JD; Bao S; Hjelmeland AB; Rich JN
Br J Cancer; 2010 Mar; 102(5):789-95. PubMed ID: 20104230
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α.
Schöning JP; Monteiro M; Gu W
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):153-161. PubMed ID: 27809360
[TBL] [Abstract][Full Text] [Related]
12. Cancer cells stemness: A doorstep to targeted therapy.
Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
[TBL] [Abstract][Full Text] [Related]
13. Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics.
Lin Q; Yun Z
Cancer Biol Ther; 2010 Jun; 9(12):949-56. PubMed ID: 20581454
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-mediated cancer stem cell resistance and targeted therapy.
Sun X; Lv X; Yan Y; Zhao Y; Ma R; He M; Wei M
Biomed Pharmacother; 2020 Oct; 130():110623. PubMed ID: 32791395
[TBL] [Abstract][Full Text] [Related]
15. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
Plaks V; Kong N; Werb Z
Cell Stem Cell; 2015 Mar; 16(3):225-38. PubMed ID: 25748930
[TBL] [Abstract][Full Text] [Related]
16. Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
Pandian V; Ramraj S; Khan FH; Azim T; Aravindan N
Stem Cell Res Ther; 2015 Feb; 6(1):2. PubMed ID: 25888913
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-mediated cancer stem cells in pseudopalisades with activation of hypoxia-inducible factor-1α/Akt axis in glioblastoma.
Inukai M; Hara A; Yasui Y; Kumabe T; Matsumoto T; Saegusa M
Hum Pathol; 2015 Oct; 46(10):1496-505. PubMed ID: 26256949
[TBL] [Abstract][Full Text] [Related]
18. Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications.
Paul R; Dorsey JF; Fan Y
Pharmacol Ther; 2022 Mar; 231():107985. PubMed ID: 34480963
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.
De Francesco EM; Sotgia F; Lisanti MP
Biochem J; 2018 May; 475(9):1611-1634. PubMed ID: 29743249
[TBL] [Abstract][Full Text] [Related]
20. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]